Jubilant Therapeutics India Limited
Jubilant Therapeutics India Limited
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor | Adenoid Cystic Carcinoma Metastatic; Adenoid Cystic Carcinoma of the Head and Neck; NSCLC Patients With EGFR Activating Mutation | Recruiting | Phase 1 | 2026-08-10 | NCT07755397 |